With an NPV of 88%, p53 codon 72 polymorphism can be used as a progression index for bladder cancer, meaning that those genotype Pro/Pro carriers of p53 codon 72 polymorphism are not likely to progress to an invasive cancer. Here, TP53 is linked to urinary bladder carcinoma.